Privia Health Group, Inc. ( PRVA ) NASDAQ Global Select

Cena: 23.76 ( -1.0% )

Aktualizacja 12-05 21:53
NASDAQ Global Select
Branża: Medycyna - Usługi informacyjne opieki zdrowotnej

Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna

symbol 1D 5D 1M 3M 6M YTD 1Y 3Y 5Y 10Y
PRVA -0.7 -2.0 -0.6 2.4 2.8 21.4 12.6 4.3 3.7 3.7
Notowania:

Opis firmy:

Privia Health Group, Inc. działa jako krajowa firma lekarska w Stanach Zjednoczonych. Firma współpracuje z grupami medycznymi, planami zdrowotnymi i systemami opieki zdrowotnej w celu optymalizacji praktyk lekarzy, poprawy doświadczeń pacjentów i nagradzania lekarzy za zapewnienie opieki osobiście i wirtualne. Oferuje technologie i narzędzia do zdrowia ludności w celu zwiększenia przepływów pracy niezależnych dostawców; Organizacja usług zarządzania, która umożliwia dostawcom skupienie się na swoich pacjentach poprzez zmniejszenie pracy administracyjnej; jednorazowa grupa medyczna, która ułatwia negocjacje płatników, integrację kliniczną i dostosowanie zachęt finansowych; Odpowiedzialna organizacja opieki, która angażuje pacjentów, ograniczają niewłaściwe wykorzystanie i zwiększają koordynację i wskaźniki jakości pacjentów w celu zwiększenia opieki opartej na wartości; oraz sieć dla nabywców i płatników, którzy umożliwiają dostawcom łączenie się z nowymi populacjami pacjentów i tworzenie niestandardowych umów. Firma została założona w 2007 roku i ma siedzibę w Arlington w stanie Wirginia. Privia Health Group, Inc. była byłą spółką zależną Brighton Health Group Holdings, LLC.

Informacje o spółce:
Sektor: Zdrowie
Branża: Medycyna - Usługi informacyjne opieki zdrowotnej
Zatrudnienie: 1 102
Giełda: NASDAQ Global Select
Ilość akcji w obrocie: 85.9419
Ilość akcji: Brak danych
Debiut giełdowy: 2021-04-28
WWW: https://www.priviahealth.com
CEO: Mr. Parth Mehrotra
Adres: 950 North Glebe Road
Siedziba: 22203 Arlington
ISIN: US74276R1023
Wskaźniki finansowe
Kapitalizacja (USD) 2 922 627 030
Aktywa: 1 135 783 000 000
Cena: 23.76
Wskaźnik Altman Z-Score: 6.27
Stabilny (niskie ryzyko bankructwa)
Dywidenda: 0
P/E: 169.7
Ilość akcji w obrocie: 86%
Średni wolumen: 832 187
Ilość akcji 123 001 529
Wskaźniki finansowe
Przychody TTM 1 900 070 000
Zobowiązania: 452 336 000 000
Przedział 52 tyg.: 18.77 - 26.51
Piotroski F-Score:
EPS: 0.1
P/E branży: 36.2
Beta: 0.761
Raport okresowy: 2026-02-26
WWW: https://www.priviahealth.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Mr. David Mountcastle CPA, MBA Executive Vice President, Chief Financial Officer & Principal Accounting Officer 713 720 1970
Mr. Parth Mehrotra Chief Executive Officer & Director 1 186 187 1979
Ms. Dana Fields CPA Chief Audit & Compliance Officer 0 0
Mr. Edward Christopher Fargis Esq. Executive Vice President, General Counsel, Chief Legal Officer & Corporate Secretary 0 0
Mr. Eric J. Beyer Executive Vice President of Medical Groups 0 0
Mr. Jay Stevens Senior Vice President & Chief Growth Officer 0 0
Mr. Sarath Degala Chief Operating Officer 0 0
Mr. Robert P. Borchert Senior Vice President of Investor Relations & Corporate Communications 0 0
Mr. Chris Voigt Executive Vice President & Chief Technology Officer 0 0
Ms. Jenny Harding Chief People Officer 0 0
Lista ETF z ekspozycją na akcje Privia Health Group, Inc.
Symbol ETF Ilość akcji Wartość
IJR.AX 6 777 325 1 483 108
IJR 6 777 325 160 893 695
XUU.TO 6 777 325 167 862
XSMH.TO 6 777 325 117 472
XSMC.TO 6 777 325 136 862
XAW.TO 6 777 325 129 767
VTI 3 481 194 84 593 014
VTS.AX 3 481 194 84 593 014
XSU.TO 2 771 909 630 543
IWM 2 771 909 65 805 119
VB 2 604 820 63 297 126
VBK 1 458 719 35 446 871
VXF 1 225 025 29 768 107
IWO 997 662 23 684 495
SPSM 995 128 22 440 080
IJT 683 737 16 231 916
VTWO 555 665 13 502 659
SCHA 554 460 12 869 265
SLYG 390 260 8 823 483
VIOO 372 550 9 052 965
DFAS 330 575 7 454 466
IJS 316 305 7 509 080
VHT 294 274 7 150 858
DFAC 246 248 5 552 892
SLYV 196 369 4 428 132
R2SC.L 182 035 3 134 452
R2US.L 182 035 4 104 889
ZPRR.DE 182 035 3 563 454
FNDA 171 782 3 993 450
KOMP 166 165 3 747 028
FESM 163 093 3 478 773
ISP6.L 159 489 2 888 923
IDP6.L 159 489 3 786 268
IUS3.DE 159 489 3 283 830
ITOT 158 581 3 764 712
XEQT.TO 158 581 241 136
XCNS.TO 158 581 2 613
XINC.TO 158 581 420
XGRO.TO 158 581 69 039
XBAL.TO 158 581 33 444
IHF 143 532 3 407 449
SXRG.DE 115 396 2 375 969
CUSS.L 115 396 2 739 501
CUS1.L 115 396 2 090 239
CSUSS.MI 115 396 2 375 969
FYC 101 154 3 143 603
VTWG 100 462 2 441 226
PSCH 99 706 2 367 020
ESML 99 277 2 356 835
RWJ 96 003 2 279 111
FYX 89 221 1 629 276
VIOG 89 072 2 164 449
PSC 83 424 1 881 211
VT 81 087 1 970 414
PRFZ 78 468 1 862 830
XRS2.DE 77 904 1 606 237
XRSU.L 77 904 1 849 438
XRSG.L 77 904 141 274 889
IUSN.DE 76 035 1 565 537
WSML.L 76 035 1 805 070
WLDS.L 76 035 1 377 269
XDBG.L 72 322 131 153 188
XBCU.L 72 322 1 716 934
VIOV 71 663 1 741 410
SCHB 70 121 1 598 710
XHS 68 543 1 545 659
RSSL 53 485 1 237 108
EDOC 51 069 1 153 648
FHLC 40 581 865 592
BBSC 37 582 892 196
ONEQ 36 573 780 102
FPX 36 206 2 359 020
FMED 35 974 767 325
ISCG 31 436 746 290
IWV 30 186 716 615
WSCR.L 29 425 662 948
WSCSRI.SW 29 425 662 948
DFUS 25 450 573 897
ESGV 24 671 599 505
JHSC 23 485 529 117
VISM.AX 22 077 819 478
WDSC.L 21 163 477 225
WOSC.L 21 163 364 404
ZPRS.DE 21 163 414 279
EES 20 912 496 450
DFAU 19 344 436 207
GSSC 18 711 396 673
SPTM 18 063 407 321
QVMS 16 887 400 897
FAD 13 052 352 135
CBUG.DE 10 359 213 288
EWSA.AS 10 359 245 922
URTY 9 771 231 963
XJR 9 586 227 571
VTHR 8 742 212 430
EDOC.L 8 542 202 872
EDOG.L 8 542 154 280
DDOC.DE 8 542 174 389
UWM 7 876 186 976
DCOR 7 857 177 175
TILT 7 599 180 400
OMFS 7 526 178 667
DFSU 7 241 163 284
ISCB 5 023 119 246
ZPRV.DE 4 888 83 017
USSC.L 4 888 95 631
STXK 3 520 79 305
DFUV 3 296 74 324
CSA 1 575 36 004
V3AM.L 1 479 27 421
V3AL.L 1 479 35 939
V3AB.L 1 479 27 421
V3AA.L 1 479 35 939
FNDB 1 478 33 954
EKG 1 439 25 354
SAA 1 270 30 149
XUH.TO 749 17 783
VLU 639 14 299
USFM.L 523 11 788
USUE.DE 523 11 788
SPYI.DE 500 9 787
IMID.L 500 11 275
CSF 489 11 178
SPGM 339 7 641
MMTM 312 7 035
HDG 147 3 489
SC0K.DE 0 0
USML.L 0 0
PZW.TO 0 10 881
RTYS.L 0 0
Wiadomości dla Privia Health Group, Inc.
Tytuł Treść Źródło Aktualizacja Link
Privia Health Group, Inc. (PRVA) Q1 2025 Earnings Call Transcript Privia Health Group, Inc. (NASDAQ:PRVA ) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Company Participants Robert Borchert - Senior Vice President-Investor and Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants Jailendra Singh - Truist Josh Raskin - Nephron Research Richard Close - Canaccord Matthew Gillmor - KeyBanc Jessica Tassan - Piper Sandler Alberta Massey - Leerink Partners A.J. Rice - UBS Thomas Walsh - Barclays Ryan Langston - TD Cowen Elizabeth Anderson - Evercore ISI Constantine Davides - Citizens JMP Jack Slevin - Jefferies Jeff Garro - Stephens Ryan Daniels - William Blair David Larsen - BTIG Matt Shea - Needham Jamie Perse - Goldman Sachs Daniel Grosslight - Citi Michael Ha - Baird Joanna Gajuk - Bank of America Operator Thank you for standing by. seekingalpha.com 2025-05-11 07:44:02 Czytaj oryginał (ang.)
Privia Health (PRVA) Reports Q1 Earnings: What Key Metrics Have to Say While the top- and bottom-line numbers for Privia Health (PRVA) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. zacks.com 2025-05-08 14:36:47 Czytaj oryginał (ang.)
Privia Health (PRVA) Misses Q1 Earnings Estimates Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.02 per share a year ago. zacks.com 2025-05-08 12:20:40 Czytaj oryginał (ang.)
Privia Health Reports First Quarter 2025 Financial Results Strong First Quarter Performance and Operating Execution Enters the State of Arizona Full-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged ARLINGTON, Va., May 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the first quarter ended March 31, 2025. globenewswire.com 2025-05-08 10:00:00 Czytaj oryginał (ang.)
Countdown to Privia Health (PRVA) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS Get a deeper insight into the potential performance of Privia Health (PRVA) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics. zacks.com 2025-05-07 14:21:36 Czytaj oryginał (ang.)
Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025 With the broader market facing volatility, a clutch of experts are recommending investors to look beyond mega-cap stocks like Meta, Amazon, and Netflix for opportunities in stocks with strong earnings growth potential. invezz.com 2025-03-04 09:03:14 Czytaj oryginał (ang.)
Here's What Key Metrics Tell Us About Privia Health (PRVA) Q4 Earnings Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com 2025-02-27 12:36:06 Czytaj oryginał (ang.)
Privia Health Group, Inc. (PRVA) Q4 2024 Earnings Call Transcript Privia Health Group, Inc. (NASDAQ:PRVA ) Q4 2024 Earnings Conference Call February 27, 2025 8:00 AM ET Company Participants Robert Borchert - Senior Vice President-Investor & Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants Sameer Patel - Evercore ISI Andrew Mok - Barclays Josh Raskin - Nephron Research Whit Mayo - Leerink Partners Jailendra Singh - Truist Securities A.J. Rice - UBS Jack Slevin - Jeffries Jeff Garro - Stephens Inc Matthew Gillmor - KeyBanc Richard Close - Canaccord Genuity Matt Shea - Needham Ryan Langston - TD Cowen David Larsen - BTIG Adam Ron - Bank of America Michael Ha - Baird Constantine Davides - Citizens JMP Daniel Grosslight - Citi Jessica Tassan - Piper Sandler Tao Qiu - Macquarie Craig Jones - Stifel Operator Thank you for standing by. seekingalpha.com 2025-02-27 11:36:51 Czytaj oryginał (ang.)
Privia Health (PRVA) Lags Q4 Earnings Estimates Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.02 per share a year ago. zacks.com 2025-02-27 10:16:07 Czytaj oryginał (ang.)
Privia Health Reports Fourth Quarter and Full-Year 2024 Financial Results All 2024 Operating and Financial Metrics Above High End of Guidance Ranges Very strong New Provider Signings with Implemented Providers +11.2% from Year-end 2023 Full-year 2024 Net Cash Provided by Operating Activities of $109.3 million, +35.3% from 2023, with De Minimis Capital Expenditures Year-end 2024 Cash Balance of $491.1 million and No Debt 2025 Guidance Reflects Continued Momentum and Profitable Growth Despite Challenging Medicare Advantage and Value-based Environment ARLINGTON, Va., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial and operating results for the fourth quarter and full year ended December 31, 2024. globenewswire.com 2025-02-27 08:00:00 Czytaj oryginał (ang.)
Seeking Clues to Privia Health (PRVA) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Privia Health (PRVA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2024. zacks.com 2025-02-25 12:20:53 Czytaj oryginał (ang.)
Privia Health to Report Fourth Quarter 2024 Results on Thursday, February 27 ARLINGTON, Va., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its fourth quarter and full-year periods ended December 31, 2024 before market open on Thursday, February 27, 2025. globenewswire.com 2025-01-24 11:00:00 Czytaj oryginał (ang.)
DH or PRVA: Which Is the Better Value Stock Right Now? Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com 2025-01-15 14:41:13 Czytaj oryginał (ang.)
DH vs. PRVA: Which Stock Is the Better Value Option? Investors with an interest in Medical Info Systems stocks have likely encountered both Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks presents investors with the better value opportunity right now? zacks.com 2024-12-20 14:45:26 Czytaj oryginał (ang.)
DH vs. PRVA: Which Stock Should Value Investors Buy Now? Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com 2024-12-04 14:46:20 Czytaj oryginał (ang.)
DH or PRVA: Which Is the Better Value Stock Right Now? Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com 2024-11-18 14:46:01 Czytaj oryginał (ang.)
Privia Health Group, Inc. (PRVA) Q3 2024 Earnings Call Transcript Privia Health Group, Inc. (NASDAQ:PRVA ) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Robert Borchert - Senior Vice President- Investor & Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants A.J. Rice - UBS Andrew Mok - Barclays Richard Close - Canaccord Genuity Jailendra Singh - Truist Securities Jamie Perse - Goldman Sachs Sameer Patel - Evercore ISI Matthew Gillmor - KeyBanc David Larsen - BTIG Jeff Garro - Stephens Ryan Langston - TD Cowen Daniel Grosslight - Citi Olivia Miles - Baird Jack Slevin - Jeffries Jessica Tassan - Piper Sandler Thomas Kelliher - RBC Capital Markets Adam Ron - Bank of America Operator Thank you for standing by. seekingalpha.com 2024-11-08 17:50:49 Czytaj oryginał (ang.)
Compared to Estimates, Privia Health (PRVA) Q3 Earnings: A Look at Key Metrics While the top- and bottom-line numbers for Privia Health (PRVA) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. zacks.com 2024-11-07 12:35:39 Czytaj oryginał (ang.)
Privia Health (PRVA) Misses Q3 Earnings Estimates Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.05 per share a year ago. zacks.com 2024-11-07 10:15:19 Czytaj oryginał (ang.)
Privia Health Reports Third Quarter 2024 Financial Results ARLINGTON, Va., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the third quarter and nine months ended September 30, 2024. globenewswire.com 2024-11-07 08:00:00 Czytaj oryginał (ang.)
Privia Health (PRVA) Earnings Expected to Grow: Should You Buy? Privia Health (PRVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com 2024-10-31 13:05:36 Czytaj oryginał (ang.)
Privia Health Reports 2023 Performance Results in the Medicare Shared Savings Program Privia Health Reports 2023 Performance Results in the Medicare Shared Savings Program; $176.6M in Shared Savings Delivered Across 10 Participating ACOs globenewswire.com 2024-10-29 19:04:00 Czytaj oryginał (ang.)
Privia Health Group, Inc. (PRVA) Q2 2024 Earnings Call Transcript Privia Health Group, Inc. (NASDAQ:PRVA ) Q2 2024 Earnings Conference Call August 8, 2024 8:00 AM ET Company Participants Robert Borchert - Senior Vice President, Investor & Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants Josh Raskin - Nephron Research Andrew Mok - Barclays Eduardo Ron - Truist Securities Elizabeth Anderson - Evercore ISI A.J. Rice - UBS Jeff Garro - Stephens Jack Slevin - Jefferies David Larsen - BTIG Richard Close - Canaccord Genuity Jessica Tassan - Piper Sandler Ryan Daniels - William Blair Michael Hall - Baird Ryan Langston - TD Cowen Daniel Grosslight - Citi Adam Ron - Bank of America Operator Hello, and thank you for standing by. seekingalpha.com 2024-08-08 16:45:26 Czytaj oryginał (ang.)
Here's What Key Metrics Tell Us About Privia Health (PRVA) Q2 Earnings Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com 2024-08-08 14:35:42 Czytaj oryginał (ang.)
Privia Health (PRVA) Lags Q2 Earnings Estimates Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.06 per share a year ago. zacks.com 2024-08-08 12:11:59 Czytaj oryginał (ang.)
Privia Health Reports Second Quarter 2024 Financial Results ARLINGTON, Va., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the second quarter and six months ended June 30, 2024. globenewswire.com 2024-08-08 10:00:00 Czytaj oryginał (ang.)
Earnings Preview: Privia Health (PRVA) Q2 Earnings Expected to Decline Privia Health (PRVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com 2024-08-01 15:05:50 Czytaj oryginał (ang.)
Privia Health to Participate in the William Blair Growth Stock Conference ARLINGTON, Va., May 30, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its management team plans to present at the 44th Annual William Blair Growth Stock Conference on Wednesday, June 5, 2024, beginning at 11:00 am ET / 10:00 am CT. globenewswire.com 2024-05-30 13:26:00 Czytaj oryginał (ang.)
Insider Buying of These 6 Stocks Surges: Fracking, Boats, a Buyout Candidate With the earnings-reporting season winding down, the windows for making insider purchases are opening up. 247wallst.com 2024-05-26 13:15:08 Czytaj oryginał (ang.)
DH or PRVA: Which Is the Better Value Stock Right Now? Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com 2024-05-13 16:46:27 Czytaj oryginał (ang.)
Privia Health Group, Inc. (PRVA) Q1 2024 Earnings Call Transcript Privia Health Group, Inc. (NASDAQ:PRVA ) Q1 2024 Earnings Conference Call May 9, 2024 8:00 AM ET Company Participants Robert Borchert – Senior Vice President-Investor and Corporate Communications Parth Mehrotra – Chief Executive Officer David Mountcastle – Chief Financial Officer Conference Call Participants A.J. Rice – UBS Sameer Patel – Evercore ISI Joshua Raskin – Nephron Research David Larsen – BTIG Richard Close – Canaccord Genuity Andrew Mok – Barclays Jeff Garro – Stephens Jack Slevin – Jefferies Jess Tassan – Piper Sandler Ryan Daniels – William Blair Whit Mayo – Leerink Partners Jailendra Singh – Truist Daniel Grosslight – Citi Adam Ron – Bank of America Operator Welcome to the Privia Health First Quarter 2024 Conference Call. seekingalpha.com 2024-05-11 14:35:24 Czytaj oryginał (ang.)
Here's What Key Metrics Tell Us About Privia Health (PRVA) Q1 Earnings The headline numbers for Privia Health (PRVA) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. zacks.com 2024-05-09 14:36:24 Czytaj oryginał (ang.)
Privia Health (PRVA) Misses Q1 Earnings and Revenue Estimates Privia Health (PRVA) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.06 per share a year ago. zacks.com 2024-05-09 12:10:27 Czytaj oryginał (ang.)